GreenLight Biosciences Holdings, PBC
DelistedCIK 1822691fmd_1F5MH12A9J3BD23H3SKP0AYQ09Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 02, 2020 to Mar 31, 2023, 11 periods
| Line item | FY2021 | FY2022 |
|---|---|---|
| Total revenues | 2 | 7 |
| Research and development | 90 | 134 |
| Total operating expenses | 110 | 171 |
| Operating income | (109) | (164) |
| Interest expense | 2 | 4 |
| Interest and investment income | 0 | – |
| Other non-operating income (expense) | (4) | (2) |
| Income before taxes | (112) | (166) |
| Income tax expense | – | 1 |
| Net income from continuing operations | – | (167) |
| Net income | (112) | (167) |